WO2003013556A1 - Medicinal compositions having effects of ameliorating eye diseases and holding eye functions - Google Patents

Medicinal compositions having effects of ameliorating eye diseases and holding eye functions Download PDF

Info

Publication number
WO2003013556A1
WO2003013556A1 PCT/JP2001/006672 JP0106672W WO03013556A1 WO 2003013556 A1 WO2003013556 A1 WO 2003013556A1 JP 0106672 W JP0106672 W JP 0106672W WO 03013556 A1 WO03013556 A1 WO 03013556A1
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
powder
eye
maintaining
function
Prior art date
Application number
PCT/JP2001/006672
Other languages
French (fr)
Japanese (ja)
Inventor
Chiduko Yamagami
Sueto Yamagami
Hiroshige Itakura
Original Assignee
Chiduko Yamagami
Sueto Yamagami
Hiroshige Itakura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiduko Yamagami, Sueto Yamagami, Hiroshige Itakura filed Critical Chiduko Yamagami
Priority to PCT/JP2001/006672 priority Critical patent/WO2003013556A1/en
Publication of WO2003013556A1 publication Critical patent/WO2003013556A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/58Reptiles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Definitions

  • composition having eye disease ameliorating action and eye function maintaining action
  • the present invention relates to a pharmaceutical composition having an effect of improving eye diseases, particularly macular degeneration.
  • eye disorders such as asthenopia and visual impairment, or pseudomyopia
  • eye disorders such as asthenopia and visual impairment, or pseudomyopia
  • lifestyle diseases such as hypertension and heart disease. It is with.
  • Eye diseases are increasing in all age groups, especially in urban areas, due to reduced opportunities to see far away and reduced greenery.
  • age-related eye diseases, cataract, macular degeneration, glaucoma, central retinopathy, and retinal detachment which are caused by aging as the number of elderly people increase, are increasing significantly.
  • the eye In China, on the other hand, the eye is called the visceral window, and it is known that improving the condition of the liver, kidney, and spleen is indispensable for maintaining the function of the eye, as is known by the term ⁇ Seimei Akimae ''. You can also see the prescription for this in the literature. (Note that “Seimei Akimie” is an authoritative dictionary published by the People's Health Publishing Company in 1995, for example, According to the report, "Seikyo Akimae is a combination of Seiko liver fever (which cools down the heat of the liver) and liver fertilizer (which nourishes the liver).
  • Seiryopyretics include white chrysanthemums, summer hay, white peony, mulberry leaves, etc., and hepatiotrope negatives include lycopodium, meisada, dry grass, and citrus soybean.
  • hepatiotrope negatives include lycopodium, meisada, dry grass, and citrus soybean.
  • many of these two drugs have both a Seongbuk action and a nourishing action, and therefore should be combined with Has been referred to as a medicine. "That there is.).
  • the pharmaceutical composition of the present invention for achieving the above object is a composition comprising a natural product having no fear of side effects as a main component, and is considered to have a peri-, antiquity, and clear-eye effect. It has a basic composition of vitamin bile and carotenoids, which have a high activity of removing active oxygen in the human body, and is difficult to treat in the past due to the synergistic effects of these components.
  • the present invention provides a pharmaceutical composition capable of obtaining a high healing effect even on an eye disease called an intractable disease, for example, age-related macular degeneration.
  • an intractable disease for example, age-related macular degeneration.
  • animal bile an ancient Chinese herbal medicine, improves the functions of the internal organs such as the liver and kidneys, enhances the natural healing power, and tries to cure eye diseases.
  • the only difference between the rate of healing and the rate of progression of the disorder appeared as a therapeutic effect.
  • Antioxidants suppress the progress of the disease by removing active oxygen, but do not have the function of remedying the existing disorders.
  • the pharmaceutical composition of the present invention stops the progress of the antioxidant scab by mixing a herbal medicine with an antioxidant having an excellent ability to remove active oxygen.
  • the resulting disorder can be cured by the herbal medicine, and the synergistic effect produces an unprecedented high therapeutic effect even on intractable diseases such as macular degeneration.
  • snake bile, sheep bile, carp bile, etc. are the most commonly used crude drugs and can be easily obtained from Chinese herbal medicine stores.
  • Carp bile contains tiprinol, vitamins A, Bl, B2, iron, phosphorus, and other minerals.It has a tonic effect, as well as a clear liver, and a detoxifying effect on the optic nerve and retina. The effect has been awarded, especially in southern China.
  • Snake gall represented by viper bile contains glycocholate and taurocholate, is rich in calcium, minerals, and vitamins. It is said to be effective for congestion and blurred vision, and is good for nutrition and tonic. Jabushi is to replace part of it with an anti-nose, which also has antipyretic activity Can be done.
  • Sheep and bile are effective against Seihe Akira, detoxification of fever, pneumocongestion, suppression of brain cell death, and epidemic conjunctivitis.
  • the antioxidant is appropriately selected and blended from vitamin C, vitamin E, astaxanthin, lycopene and the like.
  • Tomato extract powder contains lycopene, vitamin C, and polyphenol, and is effective in enhancing optic nerve function, preventing / improving age-related macular degeneration, and removing active oxygen. (The same effect can be obtained by adding lycopene and vitamin C instead of tomato powder.)
  • Astaxanthin has a high active oxygen scavenging effect of 100 to 100 times as high as vitamin E depending on its concentration (Japanese Patent No. 261991 Figure 4 and its description). Description), as well as eye diseases, good for preventing hypertension.
  • a product manufactured by Itano Frozen Co., Ltd. is commercially available.
  • fat-soluble lycopene and vitamin E are said to have their activities in the cell membrane
  • astaxanthin is mainly said to have its activity on the cell membrane surface
  • water-soluble vitamin C is in the aqueous solution such as blood and cell fluid.
  • composition of the present invention has been added to this with the addition of a pull-belly concentrate which is said to have been found effective by the Royal Air Force, but from around 1964, the contained anthocyanin was a renewal of rhodopsin, a photoreceptor of the eye. It has been understood that there is an effect of assisting synthesis, improving visual acuity in places, improving visual functions, and expanding the field of view.
  • anthocyanin also has an active oxygen removing effect and is effective in removing vascular disorders. It is also rich in vitamin C.
  • both animal-based and plant-based herbs can improve vision, reduce blood pressure, and increase arteriosclerosis. Even ingredients that are considered good,
  • the animal system is rich in beneficial minerals and is effective for flat-eyed, sedative, sedative, insomnia, headache, dizziness
  • Botanicals have a clear sensation and a fever effect, and are effective for constipation and blood lipid reduction
  • White chrysanthemum extract contains amino acids and vitamin B1, and is effective against semen detoxification, blood pressure lowering, eye strain, keratitis, conjunctivitis, and glaucoma.
  • Gugigi extract contains vitamins A, B1, B2, C, calcium, phosphorus, and iron, and is effective in strengthening the liver and kidneys, enhancing vision, and reducing blood pressure.
  • Ebisudasa also has effects on glaucoma, blurred vision, hypertension, hyperlipidemia, and constipation because it also has a clearing effect on the semen, clear feces, blood lipid reduction and blood pressure lowering.
  • Oobaco is effective in preventing semen, diuresis, cough and diarrhea, sudden chronic inflammation of eyes, glaucoma, bronchitis and urinary tract infection.
  • ginseng, rice ginseng, and cayca ground yellow stalk increase the elasticity of blood vessels
  • ginseng, kaiky ground yellow stalk, ginkgo biloba and yamagiyu have the effect of increasing blood flow by lowering blood sugar levels.
  • a synergistic effect of further improving the therapeutic effect in the affected area can be expected.
  • each component blended in the above composition is as follows.
  • Sanshu which contains persolic acid and kunnic acid, has renal function enhancement, liver protection, lowers blood pressure, and is tonic, and is used for hepatic and renal function decline and urinary dysfunction.
  • Ginseng produces resistance, enhances immunity, and enhances natural healing power. According to Shinnobu Herb, it is effective for cataracts, and saponin is also good for the optic nerve.
  • Megusulinoki is said to have the effect of detoxifying Seikan, the antipyretic effect of detoxification, stye, stye, liver disease, antibacterial activity, and control of the height of the liver.
  • Danjin ginseng powder which contains flavonoids, saboyun, amino acids and minerals, has hepato-renal strengthening, fever, prevention of eye arteriosclerosis, hemostasis, and vitality.
  • Chimney powder which contains flavonoids and limonene, has a digestive promoting effect, a stomachic-regulating effect, and has a protective effect on stomach leaning and discomfort.
  • Pearl shell powder is rich in minerals such as calcium carbonate, potassium, manganese, copper, zinc, magnesium, etc., and has an effect on erythema, corneal ulcer, cataract, and ocular fundus disease due to the effects of clearing eyes, improving visual acuity, and ulcer repair. Yes, it has the alias of "Year Pearl".
  • Edible chondroitin powder has the effect of hydrating the lens, rejuvenating and preventing retinal detachment due to aging.
  • Eighth eel enriched powder is rich in vitamins A, Ca, and iron, and is good for night blindness and strengthening the retina.
  • Kaikai ground yellow tea powder contains carotenoids and vitamin A, and is effective in reducing blood renal function, reducing renal function, diabetes, and urinary dysfunction.
  • Shiitake mushroom extract powder improves liver function, protects liver cells, and improves immune function.
  • Chisato Mitsue is rich in calcium, iron, and magnesium, and is good for cataract, conjunctivitis, chronic retinopathy, corneal vitiligo, and opacity, as well as for seizures, as well as hypertension and autonomic imbalance.
  • Dansan leaf powder is a powder of red ginseng, and red ginseng is also called “red ginseng”. It improves blood circulation and is effective for blood retention.
  • composition containing the above components in a form that can be ingested on a daily basis, it is most preferable to use a tablet for practical use.
  • An example of the manufacturing method is as follows.
  • extracts are extracted from plant components such as white chrysanthemum flower extract, gugi, ebisdasa, yamayuyu, opapa, ginseng, and megusulinoki, and concentrated to obtain a flow extract.
  • plant components such as white chrysanthemum flower extract, gugi, ebisdasa, yamayuyu, opapa, ginseng, and megusulinoki
  • carp boiled powder mamushi boiled powder, sheep boiled powder, rice field ginseng powder, chisato light powder, cock powder, etc. and mix.
  • 8th eel enriched powder Kai-Kai ground yellow stem tea powder, Shiitake mushroom extract powder, Dansan leaf powder, edible chondroitin powder, Pul ⁇ Lee concentrated powder, astaxanthin, tomato extract powder, pearl shell powder, etc.
  • Astaxanthin exhibits a particularly strong ability to scavenge active oxygen. Eliminating active oxygen means that it scavenges active oxygen by itself and is easily oxidized. In air, it oxidizes and decolorizes in about one week, and loses its ability to scavenge active oxygen. In order to constantly ingest as a pharmaceutical composition, especially a household medicine, it must be assumed that the coagulant is stored in the home for several weeks to several months. Air contact must be cut off.
  • the above (1) is not limited to astaxanthin, but is a common problem for many carotenoids.
  • coconut, / 3 carotene, lycopene, etc. are also blended, it is desirable to use micro force cells as necessary.
  • the microcapsules are ruptured due to pressure during tableting.
  • the above problem can be avoided by adsorbing on a fine powder of dextrin, silicon dioxide or the like, blending it as a carotenoid powder, or encapsulating in a microcapsule.
  • the following table shows examples of compounding amounts when one tablet is added at 40 Omg with other ingredients added.
  • microcapsules contain 12 mg of lycopene and 12 mg of astaxanthin, and the capsule film is 16 mg. Premature death
  • Dansan leaf 5.0 5.0 n.U ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
  • Example 1 used microcapsules, Examples 4 and 5 used snake bile, and reduced the amount of antioxidants such as lycopene, astaxanthin, and vitamin C. In Example 67, the combination was simplified to about five types. The effect of taking the medicine is shown below based on the experience example that was used with the consent of the subject.
  • Example 1 When the tablet of Example 1 was taken at a rate of 2 tablets twice a day, visual acuity improved to 0.8 on the right and 0.3 on the left in one and a half months. Exudation of the macula was largely absorbed, and bleeding was partially absorbed. Two months later, visual acuity improved to 0.8 on the right and 0.4 on the left. Exudation and bleeding in the macula were absorbed.
  • Example 1 When the tablet of Example 1 was taken at a rate of 2 tablets X 2 times / day, after one month, the visual acuity became 0.1 right and the central shadow was reduced, but there was no significant change in the fundus. Two months later, his visual acuity remained unchanged at 0.1, but his scotoma was thinner and his area was smaller.
  • Example 1 When one tablet of Example 1 was taken 2 times X 2 times Z days, after one month, the visual acuity became 1.5 on the right and 0.1 on the left, partially absorbing fundus hemorrhage, dilated veins, meandering Also improved. Two months later, visual acuity remained at 1.5 on the right and 0.1 on the left, but bleeding of the fundus and exudation were further absorbed, and vascular morphology recovered. At the same time, blood pressure, cholesterol, triglycerides, blood sugar, etc. recovered to normal.
  • Example 1 When 2 tablets of Example 1 were taken twice per dose, after 2 months, the visual acuity was 1.2 on the right and 0.2 on the left, the central shadow was thin, and the object was deformed. The degree has also improved.
  • the composition of Example 1 was initially prepared as a health supplement, but the results of trial use of these two cases at the Chunichi Friendship Clinic (Beijing) also helped to improve age-related macular degeneration. It has been found to have a high effect.
  • Example 1 When the tablet of Example 1 was taken 4 tablets X 3 times a day, the visual field of the central part was opened from about the sixth month. In addition, around the 10th month, the patient had almost no subjective symptoms and was diagnosed with no fear of blindness.
  • a diabetic retinopathy was announced that the likelihood of blindness was high. After taking the tablet of Example 5 for 6 months, no improvement was observed. When switching to taking the tablet of Example 1 from the seventh month, the following month saw a marked improvement, which surprised the ophthalmologist. Currently, blindness has escaped.
  • the cataract recommended surgery to the ophthalmologist.
  • monthly diagnosis confirmed that the lens turbidity had gradually disappeared.In the third month, no operation was required because the lens turbidity was removed. I was relieved.
  • the patient was diagnosed as diabetic cataract and recommended surgery.
  • the tablet of Example 6 was taken for 3 months but no improvement was observed. Taking the tablet of Example 3 from the fourth month showed some improvement. When the tablet was switched to the tablet of Example 1 from the fifth month, a remarkable improvement was seen at about the sixth month, and the blood glucose level returned to almost normal. 9. OF 62 year old man
  • Example 4 She was diagnosed with complications of cataract and glaucoma and was discouraged. The tablet of Example 4 was taken, but no improvement was observed even after 3 months. When switched to the tablet of Example 1 from the fourth month, cataracts and glaucoma also improved around the sixth month, which surprised the ophthalmologist.
  • Example 6 I started using computers, and my eyestrain became worse.
  • the tablet of Example 6 was taken three to three times, three tablets at a time, and after one week, the eyes were no longer tired. He said that he was lightly congested and his visual acuity improved.
  • Example 7 My eyes and eyes were concerned.
  • the tablet of Example 7 was taken three times a day, three tablets at a time, and stopped abruptly one week later.
  • the pharmaceutical composition of the present invention has many synergistic effects between herbal medicines introduced from Kampo medicine and antioxidants, has no fear of side effects, and is considered to be an intractable disease of many eye diseases, especially age-related eye diseases. It has an unprecedented effect in that macular degeneration also has an improving effect.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

It is said that active oxygen largely affects eye diseases. In particular, age-related macular degeneration is considered as a serious disease for which no therapeutic method has been established so far. A large amount of active oxygen is generated due to the concentration of light at the macula in the retina. It is estimated that damages due to the active oxygen are accumulated in the macula with aging, thereby resulting in the onset of macular degeneration. Medicinal compositions efficacious against these eye diseases are obtained by the combination of the recent results in Western medicine with traditional Chinese knowledge. These compositions contain as the fundamental main components animal livers, which have been employed as remedies for eye diseases for a long time, and vitamins and carotenoids having a strong effect of eliminating active oxygen from the human body. As the animal livers, use can be made of carp liver, mamushi pit viper liver and sheep liver. Examples of the antioxidants include vitamin C, vitamin E, astaxanthin and lycopene. It is favorable to add powdery blueberry concentrate having an effect of activating the re-synthesis of rhodopsin.

Description

明 細 書 眼疾患改善作用及び眼の機能維持作用を有する医薬組成物 技術分野  Description Pharmaceutical composition having eye disease ameliorating action and eye function maintaining action
この発明は眼疾患、 特に黄斑変性症の改善作用を有する医薬組成物に関する。 背景技術  The present invention relates to a pharmaceutical composition having an effect of improving eye diseases, particularly macular degeneration. Background art
コンピュータやワードプロセッサの普及に伴い、 眼精疲労や視力障害、 或は仮 性近視等の眼の障害が社会的にも問題となリ、 これが高血圧や心臓疾患などの生 活習慣病を引き起こす一因ともなつている。 特に都会においては遠方を視る機会 の減少、 緑の減少などにもよつて、 あらゆる年齢層において眼の疾患が増加して いる。 さらに、 高齢者の急増と共に老化に伴って発症する加齢眼疾患である白内 障、 黄班部変性症、 緑内障、 中心性網膜症さらには網膜剥離等が著しく増加しつ つある。  With the widespread use of computers and word processors, eye disorders such as asthenopia and visual impairment, or pseudomyopia, are becoming a social problem, and this is one of the causes of lifestyle diseases such as hypertension and heart disease. It is with. Eye diseases are increasing in all age groups, especially in urban areas, due to reduced opportunities to see far away and reduced greenery. In addition, the age-related eye diseases, cataract, macular degeneration, glaucoma, central retinopathy, and retinal detachment, which are caused by aging as the number of elderly people increase, are increasing significantly.
しかし、 これらの眼疾患の改善のための療法あるいは機能低下の予防の手段の 開発は、 十分に行われているとは言い難い。 特に、 黄班部変性症は治療が困難な 疾患として知られ、 欧米において加齢による失明の原因の最大のものであるとさ れている。 にもかかわらず、 これまで治療法が見出されておらず、 予防しか対策 がないとされながら、 予防法としては、 抗酸化ビタミンの摂取が推奨されている のみである (例えば Jacques PF "The potential preventive effects of vitami ns for cataract and age-related macular degeneration Int J Vitam Nutr Res 1999 May Vol.69 No.3 P.198- 205参照) 。  However, the development of therapies for the improvement of these eye diseases or the means of prevention of functional decline has not been sufficiently implemented. In particular, macular degeneration is known as a disease that is difficult to treat, and is considered to be the largest cause of blindness due to aging in Europe and the United States. Nevertheless, no cure has been found so far, and only preventive measures have been suggested, but only antioxidant vitamins are recommended as preventive measures (for example, Jacques PF "The potential preventive effects of vitamins for cataract and age-related macular degeneration Int J Vitam Nutr Res 1999 May Vol.69 No.3 P.198-205).
しかし、 近年、 研究の進展に伴い、 加齢性疾患を含め、 これらの眼疾患の多く 力 体内に生成される活性酸素による生体の損傷に起因することが明らかになリ つつある (例えば 「現代中医薬応用与研究大系」 第 1 3卷五官科 「眼科臨床実用 中薬」 、 吉川敏一著 「フリーラジカルの科学」 [講談社 1 9 9 9 7年 5月 1 0日 発行] 、 Christen WG.著 「抗酸化ビタミンと加齢性眼疾患」 Proc Assoc Am Phys icians 1999 Vol.111 No.l p.16 - 21参照) 。 たとえば、 網膜中、 もっとも光が集 中する黄班部においては、 集中する光によリ特に多量の活性酸素が発生するが、 加齢と共に活性酸素による障害が蓄積し、 黄斑変性症を発症するものと考えられ ている。 However, in recent years, with the progress of research, it has become clear that many of these eye diseases, including age-related diseases, are caused by damage to living organisms due to active oxygen generated in the body. "Chinese Pharmaceutical Application and Applied Research System" Vol.13, No.5, "Clinical Medicine for Ophthalmology", Toshiichi Yoshikawa, "Science of Free Radicals" [Kodansha 19 May 1997, published May 10, 2007], Christen WG , "Antioxidant Vitamin and Age-Related Eye Disease", Proc Assoc Am Physicians 1999 Vol.111 No.l p.16-21). For example, the light is most concentrated in the retina In the middle macula, concentrated light generates a particularly large amount of active oxygen, but it is thought that the damage caused by active oxygen accumulates with aging and macular degeneration develops.
一方、 中国においては眼は内臓の窓といわれ、 「清肝明目」 の語で知られるよ うに肝臓、 腎臓、 脾臓の状態の改善が眼の機能維持のために不可欠であることが 知られてぉリ、 そのための処方も文献に見ることが出来る (なお、 「清肝明目」 については、 例えば 1 9 9 5年人民衛生出版社から発行され権威ある辞典とされ ている 「中医大辞典」 によれば、 「清肝明目とは清肝熱 (肝の熱を冷す) 薬と養 肝陰 (肝の陰を養う) 薬を配合して肝熱旺盛、 肝陰不足によって起こされた眼科 疾患を治療する方法である。 清肝熱薬には白菊花、 夏枯草、 白芍、 桑葉などがあ リ、 養肝陰薬には枸杞子、 女貞子、 旱莲草、 酸棗仁などがある。 ただし、 この両 類薬の多くは、 清肝作用も養陰作用もあるので、 その故によく合わせて清肝明目 薬と呼ばれている。 」 とある。 ) 。  In China, on the other hand, the eye is called the visceral window, and it is known that improving the condition of the liver, kidney, and spleen is indispensable for maintaining the function of the eye, as is known by the term `` Seimei Akimae ''. You can also see the prescription for this in the literature. (Note that “Seimei Akimie” is an authoritative dictionary published by the People's Health Publishing Company in 1995, for example, According to the report, "Seikyo Akimae is a combination of Seiko liver fever (which cools down the heat of the liver) and liver fertilizer (which nourishes the liver). Seiryopyretics include white chrysanthemums, summer hay, white peony, mulberry leaves, etc., and hepatiotrope negatives include lycopodium, meisada, dry grass, and citrus soybean. However, many of these two drugs have both a Seongbuk action and a nourishing action, and therefore should be combined with Has been referred to as a medicine. "That there is.).
家庭常備薬品は、 摂取が医師によって管理される医薬品と異なリ、 摂取は摂取 者の自己管理に任され、 摂取者が手元において日常的に摂取するのが普通である ため、 以下の問題が生じる。  Domestic medicines are different from medicines managed by doctors, and the ingestion is left to the caretaker's self-management. .
① 摂取までの時間管理が不十分になるため、 不定期になリ易い保存期間中の変 質を防止する必要がある。  ① Since the time management until ingestion becomes insufficient, it is necessary to prevent the deterioration during the storage period, which is easy and irregular.
② どのような症状に適応して、 どの家庭常備薬品を選ぶかの判断も自己の判断 に頼ることとなるので、 出来るだけ広い症状に適応出来ることが望ましい。 ② The decision on what kind of symptom and which household medicine should be selected depends on one's own judgment, so it is desirable to be able to adapt to as wide a range of symptoms as possible.
③ 医師によって処方される一般の医薬に比して、 摂取期間が長期に及ぶので、 副作用の恐れが少ないことが条件となる。 (3) The duration of ingestion is longer than that of general medicine prescribed by a physician, so that there is little risk of side effects.
④ 摂取期間が長く、 適応症を広くするためには、 現在の症状を改善するだけで なく、 基本的な体質の改善効果を持つことが望ましい。 発明の開示  長 く In order to prolong the intake period and broaden the indications, it is desirable not only to improve the current symptoms but also to have a basic physical improvement effect. Disclosure of the invention
本発明は、 近年の研究成果と、 従来の漢方的知識の融合にょリ、 副作用の恐れ のない、 常時摂取可能な眼疾患改善作用及び眼の機能維持作用を有する医薬組成 物を得ることを目的とする。 上記目的を達成するための本発明の医薬組成物は、 副作用の恐れのない天然物 を主成分とする組成物でぁリ、 古来、 清肝明目作用を持つとされ、 眼疾患の治療 薬とされてきた動物胆末に、 人体内において高い活性酸素除去作用を持つビタミ ン、 カロチノイドを配合したものを基本組成としたものでぁリ、 これら各成分の 相乗効果によリ、 従来治療困難な難病と云われる眼疾患、 たとえば加齢性黄斑変 性症などにも高い治癒効果を得ることが出来る医薬組成物を得たものである。 すなわち、 古来の漢方生薬である動物胆は、 肝、 腎などの内臓の機能を改善し、 自然治癒力を高めて眼の疾患を治癒しょうとするが、 その間も、 一方において活 性酸素による障害は進行してぉリ、 いわば、 治癒速度と障害の進行速度の差のみ が治療効果として現れるものであった。 一方、 抗酸化剤は、 活性酸素を除去して 疾患の進行を抑制するが、 既に生じている障害を回復させる機能は有していない。 これに対して、 本発明の医薬組成物は、 漢方生薬と活性酸素除去能力に優れた 抗酸化剤とを配合することによリ、 抗酸化剤にょリ障害の進行を止め、 一方、 既 に生じた障害を生薬によって治癒することが出来るものであり、 その相乗効果に よって、 黄斑変性症のような難病に対しても従来に見ない高い治療効果を生じる ものである。 It is an object of the present invention to obtain a pharmaceutical composition having a ameliorating effect on eye diseases and a function for maintaining eye function that can be taken at all times without fear of side effects, by combining recent research results with conventional Chinese medicine knowledge. And The pharmaceutical composition of the present invention for achieving the above object is a composition comprising a natural product having no fear of side effects as a main component, and is considered to have a peri-, antiquity, and clear-eye effect. It has a basic composition of vitamin bile and carotenoids, which have a high activity of removing active oxygen in the human body, and is difficult to treat in the past due to the synergistic effects of these components. The present invention provides a pharmaceutical composition capable of obtaining a high healing effect even on an eye disease called an intractable disease, for example, age-related macular degeneration. In other words, animal bile, an ancient Chinese herbal medicine, improves the functions of the internal organs such as the liver and kidneys, enhances the natural healing power, and tries to cure eye diseases. The only difference between the rate of healing and the rate of progression of the disorder appeared as a therapeutic effect. Antioxidants, on the other hand, suppress the progress of the disease by removing active oxygen, but do not have the function of remedying the existing disorders. On the other hand, the pharmaceutical composition of the present invention stops the progress of the antioxidant scab by mixing a herbal medicine with an antioxidant having an excellent ability to remove active oxygen. The resulting disorder can be cured by the herbal medicine, and the synergistic effect produces an unprecedented high therapeutic effect even on intractable diseases such as macular degeneration.
動物の肝臓あるいは胆を使用し、 眼科疾患を治療することは、 中国における漠 方医療として古くから知られているだけでなく、 旧約聖書トビト記には目の白い 膜を天使ラファエルの教えによリ魚の胆嚢で治療する物語が見られるように、 世 界的にその効果が知られ既に 2 0 0 0年以上の歴史を有している。  The use of animal liver or gall to treat ophthalmic diseases has long been known as vague medicine in China, and in the Old Testament Tobit, the white membrane of the eyes was taught by the angel Raphael. As can be seen from the story of treating fish in the gallbladder, it has been known worldwide for its effects and has a history of more than 2000 years.
中国においては、 中でも蛇胆、 羊胆、 鯉胆等は生薬として最も普通に常用され ているものでぁリ、 漢方薬店で容易に入手出来るが、  In China, among others, snake bile, sheep bile, carp bile, etc. are the most commonly used crude drugs and can be easily obtained from Chinese herbal medicine stores.
鯉胆は、 チプリノール、 ビタミン A、 B l、 B 2、 鉄、 リン、 その他のミネラ ルを含み、 強壮作用は勿論、 清肝明目、 清熱解毒作用を持ち、 視神経や網膜にか かわる眼底疾患に効果がぁリ、 特に中国南方において賞用されている。  Carp bile contains tiprinol, vitamins A, Bl, B2, iron, phosphorus, and other minerals.It has a tonic effect, as well as a clear liver, and a detoxifying effect on the optic nerve and retina. The effect has been awarded, especially in southern China.
マムシ胆に代表される蛇胆は、 グリココール酸、 タウロコール酸を含み、 カル シユウム、 ミネラル、 ビタミン類が豊富で、 清肝明目、 清熱解毒作用が強く、 緑 内障、 眼底出血、 視力減退、 充血、 かすみ目に効果がぁリ、 滋養強壮にもよいと される。 蛇胆は、 その一部を、 同様に清熱解毒作用を持つ反鼻に置き換えること が出来る。 Snake gall represented by viper bile contains glycocholate and taurocholate, is rich in calcium, minerals, and vitamins. It is said to be effective for congestion and blurred vision, and is good for nutrition and tonic. Jabushi is to replace part of it with an anti-nose, which also has antipyretic activity Can be done.
羊胆は、 清肝明目、 清熱解毒、 気血大捕作用がぁリ、 脳細胞死抑制、 流行性結 膜炎に効果がある。  Sheep and bile are effective against Seihe Akira, detoxification of fever, pneumocongestion, suppression of brain cell death, and epidemic conjunctivitis.
とされる ( 「千金方」 による。 ) 。 (It depends on "Shinkinkata".)
本発明の組成物中、 抗酸化剤は、 ビタミン C、 ビタミン E、 ァスタキサンチン、 リコピン等の中から、 適宜に選択、 配合される。  In the composition of the present invention, the antioxidant is appropriately selected and blended from vitamin C, vitamin E, astaxanthin, lycopene and the like.
トマトエキス末は、 リコピン、 ビタミン C、 ポリフエノールを含み、 視神経の 機能亢進、 加齢黄班変性の予防/改善、 活性酸素除去に効果がある。 (トマトェ キス末は、 これに替えてリコピン、 ビタミン Cを添加することによリ、 同様の効 果を得ることが出来る。 )  Tomato extract powder contains lycopene, vitamin C, and polyphenol, and is effective in enhancing optic nerve function, preventing / improving age-related macular degeneration, and removing active oxygen. (The same effect can be obtained by adding lycopene and vitamin C instead of tomato powder.)
ァスタキサンチンは、 ビタミン Eと比較して、 濃度によっては 1 0 0〜1 0 0 0倍にも及ぶ高い活性酸素除去作用を持ち (特許第 2 6 1 9 9 1号明細書 図 4 およびその説明) 、 眼疾患だけでなく、 高血圧の予防にもよい。  Astaxanthin has a high active oxygen scavenging effect of 100 to 100 times as high as vitamin E depending on its concentration (Japanese Patent No. 261991 Figure 4 and its description). Description), as well as eye diseases, good for preventing hypertension.
とされ、 イタノ冷凍 (株)製のものが市販されている。 A product manufactured by Itano Frozen Co., Ltd. is commercially available.
これらの中、 脂溶性であるリコピン、 ビタミン Eは細胞膜内において、 ァスタ キサンチンは主として細胞膜表面においてその活性を持つとされてぉリ、 水溶性 であるビタミン Cは血液、 細胞液などの水溶液中で活性を持ち、 これらを組み合 わせることによリ、 細胞内外で生じる活性酸素の除去に高い能力を持つ組成物と することが出来る。  Among them, fat-soluble lycopene and vitamin E are said to have their activities in the cell membrane, astaxanthin is mainly said to have its activity on the cell membrane surface, and water-soluble vitamin C is in the aqueous solution such as blood and cell fluid. By having an activity and combining them, a composition having a high ability to remove active oxygen generated inside and outside the cell can be obtained.
本発明の組成物はこれに英空軍によってその効果が発見されたといわれるプル 一べリー濃縮末を加えてあるが、 1 9 6 4年頃から、 含まれるアントシァニンが 眼の受光色素であるロドプシンの再合成を助け、 喑所の視力が良くなる、 視覚機 能が良くなる、 視野が拡がるという効果があることが理解されてきた。  The composition of the present invention has been added to this with the addition of a pull-belly concentrate which is said to have been found effective by the Royal Air Force, but from around 1964, the contained anthocyanin was a renewal of rhodopsin, a photoreceptor of the eye. It has been understood that there is an effect of assisting synthesis, improving visual acuity in places, improving visual functions, and expanding the field of view.
また、 近年、 生体中の活性酸素が注目されるようになり、 上記アントシァニン は活性酸素除去作用も有してぉリ、 血管障害の除去に効果があることが判ってき た。 また、 ビタミン Cを豊富に含んでいる。  In recent years, attention has been paid to active oxygen in a living body, and it has been found that the above-described anthocyanin also has an active oxygen removing effect and is effective in removing vascular disorders. It is also rich in vitamin C.
さらに、 清肝明目作用を有する植物系の成分としてェビスダサ、 ォォバコ、 白 菊花、 枸杞子を配合するのが望ましい。  In addition, it is desirable to add ebisdasa, oobako, chrysanthemum white flower, and gingerbread as a plant-based ingredient having a clear liver action.
一般に、 動物系の生薬と植物系の生薬は、 共に視力増進、 降血圧、 動脈硬化に よいとされる成分でも、 In general, both animal-based and plant-based herbs can improve vision, reduce blood pressure, and increase arteriosclerosis. Even ingredients that are considered good,
動物系は有益なミネラルを多量に含み、 平肝明目、 鎮静作用がぁリ、 不眠、 頭 痛、 眩暈に有効  The animal system is rich in beneficial minerals and is effective for flat-eyed, sedative, sedative, insomnia, headache, dizziness
植物系は清肝明目、 清熱作用を有し、 便秘、 血中脂質減少に有効  Botanicals have a clear sensation and a fever effect, and are effective for constipation and blood lipid reduction
という相違がぁリ、 現在、 栄養学においては動物質と植物質をパランスよく摂取 することが重要であることは広く知られているが、 医薬組成物においても、 これ を組み合わせることによって、 その補完作用が認められている。 本発明の医薬組 成物に用いられる各成分は At present, it is widely known that in nutrition, it is important to take animal and plant matter in a well-balanced manner. An effect has been observed. Each component used in the pharmaceutical composition of the present invention is
白菊花エキスはアミノ酸、 ビタミン B 1を含み、 清肝明目ゃ淸熱解毒、 血圧降 下作用がぁリ、 眼精疲労、 角膜炎、 結膜炎、 緑内障に効果がある。  White chrysanthemum extract contains amino acids and vitamin B1, and is effective against semen detoxification, blood pressure lowering, eye strain, keratitis, conjunctivitis, and glaucoma.
枸杞エキスは、 ビタミン A、 B l、 B 2、 C、 カルシューム、 リン、 鉄を含み、 肝腎強化、 視力増強、 血圧降下等に効果がある。  Gugigi extract contains vitamins A, B1, B2, C, calcium, phosphorus, and iron, and is effective in strengthening the liver and kidneys, enhancing vision, and reducing blood pressure.
ェビスダサも同様に清肝明目、 清熱通便、 血中脂質減少、 血圧降下作用がある ので、 緑内障、 かすみ目、 高血圧、 高脂血症、 便秘に効果がある。  Ebisudasa also has effects on glaucoma, blurred vision, hypertension, hyperlipidemia, and constipation because it also has a clearing effect on the semen, clear feces, blood lipid reduction and blood pressure lowering.
ォォバコは、 清肝明目、 利尿消炎、 咳止め、 下痢止め作用がぁリ、 眼の急慢性 炎症、 緑内障、 気管支炎、 尿路感染に効果がある。  Oobaco is effective in preventing semen, diuresis, cough and diarrhea, sudden chronic inflammation of eyes, glaucoma, bronchitis and urinary tract infection.
さらに必要に応じ、 特に鯉胆との相乗効果の高い真珠貝末、 ェビスダサと相乗 効果の高い千里光末を配合するのがより好ましい。  Further, if necessary, it is more preferable to mix pearl mussel powder, which has a particularly high synergistic effect with carp-bile, and Ebisuda, which has a high synergistic effect, Senri Mitsue powder.
上記の基本組成にさらに山茱萸 (サンシュュ) 、 高麗人参、 メグスリノキ、 田 七人参末、 チンピ末、 八つ目鰻濃縮末、 カイケィ地黄茎茶末、 椎茸菌エキス末、 丹参葉末、 食用コンドロイチン末の中から適宜の成分をパランス良く配合して広 V、適応症を持つ医薬組成物とすることが出来る。  In addition to the basic composition described above, Sanshu, Ginseng, Megusulinoki, Shichi-jin-san, Chimpi-su, Eight-th eel enriched powder, Kai-Kai ground yellow-stalked tea powder, Shiitake fungi extract powder, Dansin leaf powder, Edible chondroitin powder Thus, a pharmaceutical composition having a wide range of indications can be prepared by blending appropriate components with good balance.
特に、 自然治癒力を高め、 抗酸化剤を患部に十分に送リ届けるためには、 血流 量を増やすことが望ましいが、 白菊花エキス、 ェビスグサ、 田七人参は血液の粘 度を下げることによって、 高麗人参、 田七人参、 カイケィ地黄茎は血管の弾力を 増し、 高麗人参、 カイケィ地黄茎、 枸杞子、 山菜萸は血糖値を下げることによつ て血流量を増やす作用を持ち、 これによつて患部における治療効果をさらに高め るという相乗効果が期待できる。  In particular, it is desirable to increase the blood flow to increase the natural healing power and to deliver the antioxidant to the affected area sufficiently.However, white chrysanthemum flower extract, evisugusa, and field ginseng should lower the blood viscosity. Thus, ginseng, rice ginseng, and cayca ground yellow stalk increase the elasticity of blood vessels, and ginseng, kaiky ground yellow stalk, ginkgo biloba and yamagiyu have the effect of increasing blood flow by lowering blood sugar levels. As a result, a synergistic effect of further improving the therapeutic effect in the affected area can be expected.
上記組成物に配合する各成分の作用は以下の通リである。 山菜萸 (サンシュュ) は、 ゥルソール酸、 クンニン酸を含み、 腎機能増強、 肝臓保 護、 血圧降下、 強壮作用を持ち、 肝腎機能の低下、 排尿障害などに用いられる。 高麗人参は、 抵抗力を作リ、 免疫力増強し、 自然治癒力を高める作用を持ち、 神農本草経によれば白内障に効くとされ、 また、 サポニンは視神経に良いとされ る。 The action of each component blended in the above composition is as follows. Sanshu, which contains persolic acid and kunnic acid, has renal function enhancement, liver protection, lowers blood pressure, and is tonic, and is used for hepatic and renal function decline and urinary dysfunction. Ginseng produces resistance, enhances immunity, and enhances natural healing power. According to Shinnobu Herb, it is effective for cataracts, and saponin is also good for the optic nerve.
メグスリノキは、 清肝明目、 清熱解毒作用がぁリ、 麦粒腫、 肝臓病、 抗菌、 肝 の高ぶりをおさえるにも効果があるとされ、 「千里眼」 、 「長者の木」 の別名を 持つ。  Megusulinoki is said to have the effect of detoxifying Seikan, the antipyretic effect of detoxification, stye, stye, liver disease, antibacterial activity, and control of the height of the liver.
田七人参末は、 フラボノイド、 サボユン、 アミノ酸、 ミネラルを含み、 肝腎強 化、 清熱、 目の動脈硬化防止、 止血、 活血作用を持ち、 その得がたい効果から 「金不換」 と呼ばれている。  Danjin ginseng powder, which contains flavonoids, saboyun, amino acids and minerals, has hepato-renal strengthening, fever, prevention of eye arteriosclerosis, hemostasis, and vitality.
チンピ末は、 フラボノイド、 リモネンを含み、 消化促進、 健胃整腸作用を持ち、 胃のもたれ、 不快感に予防効果がある。  Chimney powder, which contains flavonoids and limonene, has a digestive promoting effect, a stomachic-regulating effect, and has a protective effect on stomach leaning and discomfort.
真珠貝末は、 炭酸カルシュゥム、 カリウム、 マンガン、 銅、 亜鉛、 マグネシュ ゥム等のミネラルに富み、 清肝明目、 視力増進、 潰瘍修復作用がぁリ、 角膜潰瘍、 白内障、 眼底疾患に効果があり、 「夜明珠」 の別名を持つ。  Pearl shell powder is rich in minerals such as calcium carbonate, potassium, manganese, copper, zinc, magnesium, etc., and has an effect on erythema, corneal ulcer, cataract, and ocular fundus disease due to the effects of clearing eyes, improving visual acuity, and ulcer repair. Yes, it has the alias of "Year Pearl".
食用コンドロイチン末は、 水晶体の水分補給、 若返り、 加齢による網膜剥離の 予防作用がある。  Edible chondroitin powder has the effect of hydrating the lens, rejuvenating and preventing retinal detachment due to aging.
八つ目鰻濃縮末は、 ビタミン A、 C a、 鉄に富み、 夜盲症、 網膜の強化によい。 カイケィ地黄茎茶末は、 カロチノイド、 ビタミン Aを含み、 補血強壮、 肝腎強 化の機能がぁリ、 腎機能の低下、 糖尿病、 排尿障害などに効果がある。  Eighth eel enriched powder is rich in vitamins A, Ca, and iron, and is good for night blindness and strengthening the retina. Kaikai ground yellow tea powder contains carotenoids and vitamin A, and is effective in reducing blood renal function, reducing renal function, diabetes, and urinary dysfunction.
椎茸菌エキス末は、 肝臓細胞保護作用にょリ肝機能を改善し、 免疫機能を向上 させる。  Shiitake mushroom extract powder improves liver function, protects liver cells, and improves immune function.
千里光末 (ァヮビ貝殻末) は、 カルシウム、 鉄、 マグネシウムに富み、 清肝明 目だけでなく、 白内障、 結膜炎、 慢性網膜症、 角膜白班、 混濁によく、 さらに高 血圧、 自律神経失調症に効く。  Chisato Mitsue is rich in calcium, iron, and magnesium, and is good for cataract, conjunctivitis, chronic retinopathy, corneal vitiligo, and opacity, as well as for seizures, as well as hypertension and autonomic imbalance. Works.
丹参葉末は、 丹参の葉の粉末で、 丹参は 「赤参」 とも呼ばれ、 血のめぐリを良 くし、 血の滞リに有効である。  Dansan leaf powder is a powder of red ginseng, and red ginseng is also called “red ginseng”. It improves blood circulation and is effective for blood retention.
これらは何れも漢方薬店で容易に入手可能なものである。 発明を実施するための最良の形態 All of these are easily available at Chinese medicine stores. BEST MODE FOR CARRYING OUT THE INVENTION
上記成分を含む組成物を医薬組成物として日常的に摂取可能な形で提供するに は、 実用的には錠剤とするのが最も好ましい。 その製法の 1例を示せば以下のよ うである。  In order to provide the composition containing the above components as a pharmaceutical composition in a form that can be ingested on a daily basis, it is most preferable to use a tablet for practical use. An example of the manufacturing method is as follows.
まず、 白菊花エキス、 枸杞、 ェビスダサ、 山菜萸、 ォォパコ、 高麗人参、 メグ スリノキなどの植物成分からエキスを抽出し、 濃縮して流エキスとする。 これに 鯉胆末、 マムシ胆末、 羊胆末、 田七人参末、 千里光末、 チンピ末、 などを加えて 混合する。 これにさらに、 八つ目鰻濃縮末、 カイケィ地黄茎茶末、 椎茸菌エキス 末、 丹参葉末、 食用コンドロイチン末、 プル一^ ^リー濃縮末、 ァスタキサンチン、 トマトエキス末、 真珠貝末などを配合し、 タンパク質、 ミネラル、 ビタミン類に 富む蜂蜜末、 およびビフィズス菌の栄養素であるオリゴ糖を加え、 打錠する。 この方法によれば、 ほとんど賦形剤を必要とせず、 有効成分の比率の高い組成 物を得ることが出来る。  First, extracts are extracted from plant components such as white chrysanthemum flower extract, gugi, ebisdasa, yamayuyu, opapa, ginseng, and megusulinoki, and concentrated to obtain a flow extract. Add carp boiled powder, mamushi boiled powder, sheep boiled powder, rice field ginseng powder, chisato light powder, cock powder, etc. and mix. In addition, 8th eel enriched powder, Kai-Kai ground yellow stem tea powder, Shiitake mushroom extract powder, Dansan leaf powder, edible chondroitin powder, Pul ^^ Lee concentrated powder, astaxanthin, tomato extract powder, pearl shell powder, etc. Combine, add honey powder rich in protein, minerals and vitamins, and oligosaccharides, a nutrient of bifidobacteria, and compress. According to this method, a composition having a high ratio of the active ingredient can be obtained with little need for excipients.
上記成分中、 特にァスタキサンチンについては、 以下の理由によってマイクロ カプセルに封入して混入することが望ましい。  Of the above components, particularly astaxanthin, it is desirable to mix in microcapsules for the following reasons.
① ァスタキサンチンは、 特に強い活性酸素消去能力を示す。 活性酸素を消去す るということは、 それ自身は活性酸素を'捕捉して酸化され易いことを意味し、 空 気中においては 1週間程度で酸化脱色し、 活性酸素消去能力を失う。 医薬組成物、 特に家庭常備薬品として常時摂取するためには、 凝剤が数週間ないし数か月は家 庭等において保存されることを前提としなければならないので、 その間の酸化を 防止するため、 空気との接触を遮断しなければならない。  ① Astaxanthin exhibits a particularly strong ability to scavenge active oxygen. Eliminating active oxygen means that it scavenges active oxygen by itself and is easily oxidized. In air, it oxidizes and decolorizes in about one week, and loses its ability to scavenge active oxygen. In order to constantly ingest as a pharmaceutical composition, especially a household medicine, it must be assumed that the coagulant is stored in the home for several weeks to several months. Air contact must be cut off.
② 食品として使用が認められている天然物由来のァスタキサンチンは、 酵母、 緑藻、 ォキアミなどの甲殻類から抽出されるが、 特有の強い臭気がある。 クロマ トグラフィ一などによって精製すれば無臭化は可能であるが、 極端に高価 (純度 ② Astaxanthin derived from natural products, which is approved for use as food, is extracted from crustaceans such as yeast, green algae, and krill, but has a peculiar strong odor. Deodorization is possible by purification using chromatography, but extremely expensive (purity
1 0 0 %にしようとすれば数百万円 K g ) なものとなリ、 医薬組成物として日 常的に摂取するには不適当なものとなる。 If it is set to 100%, it will be several million yen Kg), which is unsuitable for daily ingestion as a pharmaceutical composition.
③ 錠剤をセラックなどでコートし、 摂取時に臭を抑えたとしても、 ゲップなど による戻リ臭が強く、 これを消すためには腸溶性のカプセルに封入することが望 ましい。 しかし、 配合成分中には、 例えば真珠貝末、 千里光末など、 胃液の作用 を必要とする成分もぁリ、 錠剤全体を膳溶性のカプセルに封入することは出来な い。 ③ Even if tablets are coated with shellac etc. and the odor is suppressed during ingestion, the returning odor due to burp etc. is strong, and it is desirable to enclose them in enteric capsules to eliminate this. Good. However, some of the ingredients that require the action of gastric juice, such as pearl mussel powder and Chisato Mitsue powder, cannot be encapsulated in whole tablets.
④ ァスタキサンチンに限らず、 抗酸化剤は、 自身が酸化され、 活性酸素消去能 力を失ったものは、 かえって生体に酸化的ダメージを与えることが知られている。 このため、 上記のように保存期間中の酸化を防止することは極めて重要である。 それだけでなく、 カプセル溶解後に、 腸内に存在する空気、 消化液との接触時間 をなるぺく短縮することが望ましいことはいうまでもない。 従って、 マイクロ力 プセルに封入することによリ、 保存中の酸化を防止すると共に、 腸内には細粒の 形で供給され、 吸収可能なまでに乳化する時間を出来るだけ短縮することが望ま しい。  Not only astaxanthin, but also antioxidants that are themselves oxidized and lose their ability to scavenge active oxygen, are known to cause oxidative damage to living organisms. Therefore, it is extremely important to prevent oxidation during the storage period as described above. In addition, it is needless to say that it is desirable to shorten the contact time with air and digestive juices present in the intestine after dissolving the capsule. Therefore, it is desirable to prevent the oxidation during storage by encapsulating in a micro force capsule, and to minimize the time for emulsification until it is supplied in the intestine in the form of fine particles and can be absorbed. New
上記の①④は、 ァスタキサンチンに限らず、 多くのカロチノイドに共通した間 題でぁリ、 /3カロチン、 リコピンなども配合する場合は必要に応じてマイクロ力 プセル化することが望ましい。 しかし、 リコピンなど、 粘性の極めて高い成分を マイクロカプセルにそのまま封入することは困難である。 また、 封入したマイク 口カプセルを配合しても、 打錠時に、 圧力に因ってマイクロカプセルが破壌され てしまうという問題が生じる。  The above (1) is not limited to astaxanthin, but is a common problem for many carotenoids. In the case where coconut, / 3 carotene, lycopene, etc. are also blended, it is desirable to use micro force cells as necessary. However, it is difficult to encapsulate very viscous components such as lycopene in microcapsules. In addition, even if the encapsulated microcapsules are blended, there is a problem that the microcapsules are ruptured due to pressure during tableting.
このため、 デキストリン、 二酸化珪素等の微粉末に吸着させ、 カロチノイド末 として配合、 あるいはマイクロカプセルに封入することによって上記の問題を回 避することが出来る。  For this reason, the above problem can be avoided by adsorbing on a fine powder of dextrin, silicon dioxide or the like, blending it as a carotenoid powder, or encapsulating in a microcapsule.
試験例 Test example
本発明組成物の効果を見るため、 動物胆と抗酸化剤とを併用摂取した場合を動 物胆のみ、 抗酸化剤のみの場合と比較した。 疲れ眼、 かすみ眼、 白内障、 緑内障 等の眼の障害を有する患者各 3 0名を 3つのグループに分け、 第 1グループには 動物胆として鯉胆を 5 O ni g 日、 第 2グループには抗酸化剤としてァスタキサ ンチンを 2 O m g /日、 第 3グループには鯉胆 5 O m gおよびァスタキサンチン 2 O m g /日を 1か月投与した。 その結果、 有意の改善を見た患者の割合 (%) は以下のようであった。 障害 mm スタ サノテン 鯉 £Lと?スタ サンテン 波れ眼 y υ o υ 丄 U U In order to see the effect of the composition of the present invention, the case where the animal bile and the antioxidant were taken together was compared with the case where only the animal bile was used and the case where the antioxidant was used alone. Each of the 30 patients with eye disorders such as tired eyes, blurred eyes, cataracts, and glaucoma was divided into three groups. Astaxanthin was administered as an antioxidant at 2 O mg / day, and the third group was administered carp bile 5 O mg and astaxanthin 2 O mg / day for 1 month. As a result, the percentage of patients who showed significant improvement was as follows. Obstacle mm Star Sanoten Carp £ L? Star Santen Waved eyes y υ o υ 丄 UU
: it皿 ο υ o U Q Π  : It dish ο υ o U Q Π
かすみ眼 50 30 1 00  Blurred eyes 50 30 1 00
白内障 40 40 90  Cataract 40 40 90
緑内障 30 30 80  Glaucoma 30 30 80
黄斑変性症 30 20 70 配合例  Macular degeneration 30 20 70 Combination example
その他の成分を加え 1錠を 4 0 Omgとした場合の配合量の例を以下の表に示 す。  The following table shows examples of compounding amounts when one tablet is added at 40 Omg with other ingredients added.
実施例 1  Example 1
成分 m g 成分 m g 鯉胆 25.0 チンピ末 5.0 高麗人参 20.0 蛇胆 5.0 田七人参 40.0 ォオノ コ 3.0 真珠貝 30.0 メダスリの木 3.0 八ッ目鰻 2.0 *マイクロカプセノレ 40.0 白菊花 20.0 小麦胚芽 3.0 枸杞 20.0 椎茸菌エキス 5.0 ハブ茶 (ェビスダサ) 5.0 丹参葉 5.0 カイケィ地黄茎茶 10.0 3.0 オリゴ糖 3.0 ビタミン E 10.0 羊胆 15.0 ビタミン C 40.0 プルーベリ一 20.0 反鼻 5.0 コンドロイチン 10.0 ¾血藤末 5.0 蜂蜜 10.0 賦形剤 8.0 千里光 30.0  Ingredients mg Ingredients mg Carp gall 25.0 Chimney powder 5.0 Ginseng 20.0 Snake ginseng 5.0 Field ginseng 40.0 White pearls 3.0 Pearls 30.0 Medsuri tree 3.0 Eight eyes eel 2.0 * Microcapsenole 40.0 White chrysanthemum flower 20.0 Wheat germ 3.0 Glucium 20.0 Shiitake fungi extract 5.0 Hub tea (Ebisudasa) 5.0 Dansin leaves 5.0 Kaikei ground yellow stalk tea 10.0 3.0 Oligosaccharides 3.0 Vitamin E 10.0 Sheep bile 15.0 Vitamin C 40.0 Pluveli 12.0 Anti-nose 5.0 Chondroitin 10.0 10.0Blood stomach 5.0 Honey 10.0 Excipient 8.0 Chisatomitsu 30.0
計 400.0 *マイクロカプセルは、 リコピン 1 2mg、 ァスタキサンチン 1 2mgを含 み、 カプセル皮膜は 1 6 mgである。 夭她 Total 400.0 * The microcapsules contain 12 mg of lycopene and 12 mg of astaxanthin, and the capsule film is 16 mg. Premature death
乂刀 m g m g  Sword m g m g
^ S田胆 BFt a. U 0. u  ^ S Tabile BFt a. U 0. u
c n  c n
ί¾麗人 ZU- U ii U  ί¾ 美人 ZU- U ii U
{±1 人 4U. li o onU. U  (± 1 person 4U.li o onU.U
亩 Kb曰 4U. U 4U- U  亩 Kb says 4U.U 4U- U
八ッ目 L, U し U  Eighth L, U then U
on  on
ィ匕 U. U 匕
¾)不 d U. U U. U  ¾) Not d U. U U. U
ハ (マ 、、マ ガ、  C (ma, ma, ma,
ノヽノ エしスク 0. U  ヽ
ィグっ ¾B¾¾: r 1U. u U. u  Fig ¾B¾¾: r 1U.u U.u
Λ リ 概 1U . u  Overview 1U.
手胆 丄 U U. u  胆 U U. u
ノノレ ソ 9Π . Π u 丄 u Π u  ノ u 丄 u Π u
ノ 卜ロイァノ 丄 U U 丄 u u  No Troiano 丄 U U 丄 u u
1U u 丄 u u  1U u 丄 u u
Π U. U  Π U. U
十 n  Ten n
ナノし术 0. U 1U u  Nanoshu 0. U 1U u
q (  q (
匕胆 0. u 0. U  Dagger 0. u 0. U
ォォパコ 3.0 20.0  Wopaco 3.0 20.0
メダスリの木 3.0 5.0  Medsuri tree 3.0 5.0
リコピン 3.0 3.0  Lycopene 3.0 3.0
小麦胚芽 3.0 3.0  Wheat germ 3.0 3.0
ァスタキサンチン 2.0 2.0  Astaxanthin 2.0 2.0
椎茸菌エキス 5.0  Shiitake fungus extract 5.0
丹参葉 5.0 5.0 n . U , し、、々 、 、ノ ? n n n n ドし々ゾ ;、 ソ し 4 4Πυ . n Λ(\ n u 4U 反鼻 5.0 5.0 鶏血藤末 5.0 4.0 賦形剤 13.0 15.0 計 400.0 400.0 Dansan leaf 5.0 5.0 n.U ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,.
J 刀 m g m gJ sword m g m g
^田 U z. u 局麗人参 ^ Ta U z. U Bureau ginseng
λ  λ
4U. U 4U. U 具珠 5U,U 50.0 八ッ目錢 · u  4U.U 4U.U beads 5U, U 50.0
曰菊ィ匕 Zo. U Sakura
0 / . U D · U ハプ茶 (ェビスダサ) 23.0 23.0 カイケィ地黄茎茶 40.0 40.0 オリゴ糖 3.0 5.0 羊胆 15.0 10.0 プルーベリ一 5.0 15.0 コンドロイチン 25.0 25.0 蜂蜜 20.0 20.0 千里光 3.0 5.0 チンピ末 10.0 10.0 蛇胆 3.0 10.0 ォォパコ 12.0 12.0 メグスリの木 3.0 3.0 1 マ 1 ェ ス ps. 9 0 9 (Ί UD · U Hap tea (Ebisudasa) 23.0 23.0 Kaikei ground yellow stalk tea 40.0 40.0 Oligosaccharides 3.0 5.0 Sheep bile 15.0 10.0 Pluveli 5.0 5.0 15.0 Chondroitin 25.0 25.0 Honey 20.0 20.0 Chisatomitsu 3.0 5.0 Chimpi powder 10.0 10.0 Snake boil 3.0 10.0 Oopako 12.0 12.0 Metzuri tree 3.0 3.0 1 mass 1 ps. 9 0 9 (Ί
ァスタ yつサンチン 1 71  Asta y Santin 1 71
, (ヽ旁 苹 i n o  , (ヽ
維昔 ェ フ  Ifu
丹参葉末 c 5.0  Dansan leaf end c 5.0
鶏血藤末 5.0  Chicken blood wisteria 5.0
賦形剤 28.0 34. 3  Excipient 28.0 34.3
計 400.0 400.0 実施例 6 実施例 7  Total 400.0 400.0Example 6 Example 7
成分 m g 成分 m g ァスタキサンチン 12 ァスタキサンチン 12 鯉胆 25 リコピン 12 ブルーべリ - 20 鯉胆 25 メダスリの木 30 ェビスグサ 50 枸杞 60 白菊花 50 賦形剤 153 賦形剤 151  Ingredients mg Ingredients mg Astaxanthin 12 Astaxanthin 12 Kobile 25 Lycopene 12 Blue Berry-20 Kobile 25 Medsuri tree 30 Ebisugusa 50 Mushroom 60 White chrysanthemum flower 50 Excipient 153 Excipient 151
計 300 計 300 実施例 1はマイクロカプセルを用いたもの、 実施例 4 , 5は、 蛇胆、 およぴリ コピン、 ァスタキサンチン、 ビタミン Cなどの抗酸化剤の配合を減じたもの、 実 施例 6 7は配合剤を 5種程度に簡略化したものである。 以下、 被験者の了解のもとに試用した体験例によリ服用の効果を示す。  Total 300 Total 300 Example 1 used microcapsules, Examples 4 and 5 used snake bile, and reduced the amount of antioxidants such as lycopene, astaxanthin, and vitamin C. In Example 67, the combination was simplified to about five types. The effect of taking the medicine is shown below based on the experience example that was used with the consent of the subject.
1 . A. 李 6 8歳 男性 1. A. Lee 6 8 year old male
左眼に視力障害が出て 1か月後に診断を受けた。 視力低下、 視野中心に暗影が 見られ、 ものを見ると変形する症状があった。 視力は右 0 . 6、 左が 0 . 2にま で低下してぉリ、 黄斑部に滲出と出血が見られ、 範囲は約 1 P Dで黄斑部下に硬 性滲出がぁリ、 中心窩光反射が見えないので、 加齢性黄斑変性症 (滲出型) と診 断された。 She was diagnosed one month after visual impairment in her left eye. She had poor vision and a dark shadow in the center of the visual field. Visual acuity decreased to 0.6 on the right and 0.2 on the left, and bleeding and bleeding were observed in the macula.The extent was about 1 PD, with hard bleeding under the macula and foveal fovea. Diagnosis of age-related macular degeneration (wet type) Refused.
実施例 1の錠剤を 2粒 X 2回/ョずつ服用したところ、 1か月半で視力が右 0. 8、 左 0. 3に向上した。 黄斑部の滲出も大部分吸収され、 出血も部分的に吸収 された。 2か月後に視力は右 0. 8、 左 0. 4まで向上し、 中心暗影は薄くなリ、 視物変形が消失した。 黄斑部の滲出と出血は吸収された。  When the tablet of Example 1 was taken at a rate of 2 tablets twice a day, visual acuity improved to 0.8 on the right and 0.3 on the left in one and a half months. Exudation of the macula was largely absorbed, and bleeding was partially absorbed. Two months later, visual acuity improved to 0.8 on the right and 0.4 on the left. Exudation and bleeding in the macula were absorbed.
2. S . 劉 65歳 男性  2. S. Liu, 65, male
右眼視力障害 1年と訴えて診断を受けた。 視力は右 0. 07 (左 1. 5) まで 低下していた。 黄斑部耳側に楕円形網膜萎縮班が見られ、 その範囲は約 4 PDで、 その中に点状出血と脈絡血管新生も見られ、 右眼加齢性黄斑変性症 (萎縮型) と 診断された。  Right eye visual impairment She was diagnosed for one year. Visual acuity had decreased to the right 0.07 (1.5 left). Elliptical retinal atrophy spots on the ear side of the macula, with a range of about 4 PD, petechial hemorrhage and choroidal neovascularization in them, and diagnosis of age-related macular degeneration (atrophic type) in the right eye Was done.
実施例 1の錠剤を 2粒 X 2回/日ずつ服用したところ、 1か月後、 視力が右 0. 1になリ、 中心暗影も縮小していたが、 眼底では大きい変化はなかった。 2か月 後には、 視力は右 0. 1と変化はなかったが、 眼の前暗点は薄くなリ、 範囲も縮 小していた。  When the tablet of Example 1 was taken at a rate of 2 tablets X 2 times / day, after one month, the visual acuity became 0.1 right and the central shadow was reduced, but there was no significant change in the fundus. Two months later, his visual acuity remained unchanged at 0.1, but his scotoma was thinner and his area was smaller.
3. H. 王 43歳 男性  3. H. Wang, 43, male
突然左目が見えなくなリ診断を受けた。 視力は右は 1. 5であったが、 左は 0. 05まで低下していた。 眼底に視神経乳頭浮腫、 網膜静脈に顕著な拡張および蛇 行が見られた。 右眼にも小斑状出血が散在してぉリ、 網膜静脈閉塞症と診断され た。  Suddenly I got a diagnosis that my left eye was not visible. Visual acuity was 1.5 on the right, but decreased to 0.05 on the left. There was optic disc edema in the fundus and marked dilation and meandering in the retinal veins. Small ecchymosis was also scattered in the right eye, and retinal vein occlusion was diagnosed.
実施例 1の錠剤を 2粒 X 2回 Z日ずつ服用したところ、 1か月後、 視力が右 1. 5、 左 0. 1になり、 眼底出血も部分吸収し、 静脈の拡張、 蛇行にも改善が見ら れた。 2か月後には、 視力は右 1. 5、 左 0. 1のままであつたが、 眼底出血お よび滲出もさらに吸収され、 血管形態も回復した。 同時に、 血圧、 コレステロ一 ル、 中性脂肪、 血糖値なども正常に回復した。  When one tablet of Example 1 was taken 2 times X 2 times Z days, after one month, the visual acuity became 1.5 on the right and 0.1 on the left, partially absorbing fundus hemorrhage, dilated veins, meandering Also improved. Two months later, visual acuity remained at 1.5 on the right and 0.1 on the left, but bleeding of the fundus and exudation were further absorbed, and vascular morphology recovered. At the same time, blood pressure, cholesterol, triglycerides, blood sugar, etc. recovered to normal.
4. Y. 劉 55歳 男性  4. Y. Liu, 55, male
左眼視力障害を訴えて診断を受けた。 二年ほど前、 左眼が突然見えなくなり、 ある病院で網膜中央静脈閉塞症と診断され、 1か月の入院治療を受けた。 しかし、 受診時も左眼中心暗点がひどく、 ものがはっきリ見えなかった。 眼底検査の結果、 網膜血管のねじれ形成、 静脈拡張迂曲、 黄斑部に 1Z2PD萎縮斑、 色素沈着が 見られ、 網膜静脈閉塞症 (黄斑病変) と診断された。 視力は右 1 . 2、 左 0 . 1 であった。 He was diagnosed with left eyesight impairment. About two years ago, my left eye suddenly disappeared, and at a hospital I was diagnosed with central retinal vein occlusion and received one month of hospitalization. However, the scotoma at the center of the left eye was too bad at the time of consultation, and I could not see anything clearly. Fundus examination showed retinal blood vessel torsion, vein dilation, 1Z2PD atrophy in the macula, and pigmentation The patient was diagnosed with retinal vein occlusion (macular lesion). Visual acuity was 1.2 on the right and 0.1 on the left.
実施例 1の錠剤を 2粒 X 2回/ョずつ服用したところ、 2か月後、 視力が右 1 . 2、 左 0 . 2になリ、 中心喑影も薄くなリ、 物を見る変形の程度も改善した。 実施例 1の組成物は、 はじめは健康捕助食品として調製されたものであるが、 中日友好医院 (北京) におけるこの 2例の試用結果にょリ、 加齢性黄斑変性症の 改善にも高い効果を有することが発見された。  When 2 tablets of Example 1 were taken twice per dose, after 2 months, the visual acuity was 1.2 on the right and 0.2 on the left, the central shadow was thin, and the object was deformed. The degree has also improved. The composition of Example 1 was initially prepared as a health supplement, but the results of trial use of these two cases at the Chunichi Friendship Clinic (Beijing) also helped to improve age-related macular degeneration. It has been found to have a high effect.
5 . T. S . 6 2歳 女性  5. T.S. 6 2-year-old female
視野の中心部が見えなくなリ、 眼科で検査の結果、 加齢黄斑変性症と診断され た。 国際的に途中失明原因の第 1と認められていると聞き驚いたが、 色素上皮細 胞の変性によるものであリ、 治療法も確立されていない難病であると説明され、 ショックを受けた。  The central part of the visual field became invisible, and as a result of examination by an ophthalmologist, age-related macular degeneration was diagnosed. I was surprised to hear that it was recognized as the first cause of blindness internationally, but was shocked to explain that it was due to degeneration of pigment epithelial cells and that there was no cure for it. .
実施例 1の錠剤を 4粒 X 3回 日ずつ服用したところ、 6か月目頃から中心部 の視野が開けてきた。 さらに、 1 0か月目頃にはほとんど自覚症状はなくなリ、 失明の恐れはないと診断された。  When the tablet of Example 1 was taken 4 tablets X 3 times a day, the visual field of the central part was opened from about the sixth month. In addition, around the 10th month, the patient had almost no subjective symptoms and was diagnosed with no fear of blindness.
6 . A. J . 6 0歳 女  6. A. J. 60-year-old woman
糖尿病性網膜症で、 失明の可能性が高いと告知された。 実施例 5の錠剤を 6か 月服用したが、 改善が見られなかった。 7か月目から実施例 1の錠剤の服用に切 リ替えると、 翌月には顕著な改善が見られ、 眼科医に驚かれた。 現在、 失明は免 れている。  A diabetic retinopathy was announced that the likelihood of blindness was high. After taking the tablet of Example 5 for 6 months, no improvement was observed. When switching to taking the tablet of Example 1 from the seventh month, the following month saw a marked improvement, which surprised the ophthalmologist. Currently, blindness has escaped.
7 . S . I . 5 5歳 女  7 .S.I.5 5 year old woman
白内障で眼科医には手術を勧められた。 実施例 1の錠剤を服用し始ると、 毎月 の診断で水晶体の濁リが徐々に消えていることが確認され、 3か月目には水晶体 の濁リがとれとして、 手術の必要はないとのことで安堵した。  The cataract recommended surgery to the ophthalmologist. When taking the pill of Example 1, monthly diagnosis confirmed that the lens turbidity had gradually disappeared.In the third month, no operation was required because the lens turbidity was removed. I was relieved.
8 . N. K. 6 7歳 男  8. N.K. 6 7 year old male
糖尿病性白内障と診断され、 手術を勧められた、 実施例 6の錠剤を 3力月服用 したが改善が見られなかった。 4か月目から実施例 3の錠剤を服用すると、 ある 程度の改善が見られた。 5か月目からは実施例 1の錠剤に切リ替えると、 約 6か 月目には顕著な改善が見られ、 血糖値もほぼ正常に戻った。 9. O. F. 62歳 男 The patient was diagnosed as diabetic cataract and recommended surgery. The tablet of Example 6 was taken for 3 months but no improvement was observed. Taking the tablet of Example 3 from the fourth month showed some improvement. When the tablet was switched to the tablet of Example 1 from the fifth month, a remarkable improvement was seen at about the sixth month, and the blood glucose level returned to almost normal. 9. OF 62 year old man
白内障と緑内障の合併症と診断され、 落胆した。 実施例 4の錠剤を飲んだが、 3か月たつても改善は見られなかった。 4か月目から実施例 1の錠剤に切リ替え ると、 6か月目頃から白内障はもとょリ、 緑内障にも改善が見られ、 眼科医を驚 かせた。  She was diagnosed with complications of cataract and glaucoma and was discouraged. The tablet of Example 4 was taken, but no improvement was observed even after 3 months. When switched to the tablet of Example 1 from the fourth month, cataracts and glaucoma also improved around the sixth month, which surprised the ophthalmologist.
10. Y. M. 56歳 男  10. Y.M. 56 year old male
緑内障で視野が狭くなリ、 仕事、 生活に不自由をきたしていた。 実施例 2の錠 剤を飲み始めて 3か月目に視野の広がリを感じ、 検査の結果、 緑内障が顕著に改 善されておリ、 失明の恐れは無くなっているとのことであった。  She had narrow gaze due to glaucoma, and had difficulty working and living. Three months after starting to take the tablet of Example 2, the field of vision was widened, and as a result of the examination, glaucoma was remarkably improved, and there was no fear of blindness. .
11. M. O. 45歳 女  11. M.O. 45-year-old woman
リューマチのため、 ステロイ ドを半年間服用していたら、 ステロイドの副作用 で水晶体が濁リ、 白内障と診断された。 ステロイドの服用を中止し、 実施例 3の 錠剤を 6か月間服用したところ、 白内障の手術をしないで済むまでに回復した。 If she had been taking steroids for half a year due to rheumatism, she had been diagnosed with cataracts due to lens turbidity due to side effects of steroids. The steroid was discontinued, and the tablet of Example 3 was taken for 6 months. The patient recovered before cataract surgery was performed.
12. K. N. 61歳 女 12. K. N. 61-year-old woman
3か月間、 飛蚊症で悩んでぉリ、 網膜剥離および緑内障の前兆と診断された。 日に 3回、 3粒ずつ実施例 4の錠剤を服用し、 3週間目に飛蚊症が消えた。  For three months, she was diagnosed with pterodactylosis, a sign of retinal detachment and glaucoma. Taking the tablet of Example 4 three times a day three times a day, the fly mosquito disappeared in the third week.
13. Y. S. 35歳 男  13. Y.S. 35 year old male
外出すると目が充血し、 酒を飲むとさらに充血がひどかった。 日に 3回、 3粒 ずつ実施例 5の錠剤を服用し、 1か月後にすつかリ充血しなくなった。  When I went out, my eyes became reddened, and when I drank alcohol, my redness was even worse. He took the tablet of Example 5 three times a day, three tablets at a time, and one month later, he did not fully congest.
14. T. S. 35歳 男  14. T.S. 35-year-old man
コンピュータを使うようになって、 眼精疲労がひどくなつた。 3に 3回、 3粒 ずつ実施例 6の錠剤を服用し、 1週間後には眼の疲れを感じなくなった。 充血も 軽くなリ、 視力も良くなつた気がすると話している。  I started using computers, and my eyestrain became worse. The tablet of Example 6 was taken three to three times, three tablets at a time, and after one week, the eyes were no longer tired. He said that he was lightly congested and his visual acuity improved.
15. M. H. 50歳 男  15. M.H. 50 year old man
眼がかすんで新聞も読みずらかった。 日に 3回、 4粒ずつ実施例 6の錠剤を服 用し、 わずか 3日目にかすみがとれた。  The eyes were blurred and the newspaper was hard to read. Taking the tablet of Example 6 four times a day three times a day, the haze was removed only on the third day.
16. K. Y. 58歳 女  16. K. Y. 58-year-old woman
涙が止まらず、 視力も 1. 0から 0. 2まで低下した。 日に 3回、 4粒ずつ実 施例 7の錠剤を服用し、 2週間後に涙が止まった。 服用を続けて約 1か月後には、 視力が 0. 5にまで回復してきた。 My tears didn't stop and my eyesight dropped from 1.0 to 0.2. Taking the tablet of Example 7 three times a day, four tablets at a time, tears stopped after two weeks. After about a month of taking it, My eyesight has recovered to 0.5.
17. T. T. 65歳 女 17. T. T. 65-year-old woman
目やにがひどく悩んでいた。 日に 3回、 3粒ずつ実施例 7の錠剤を服用し、 1 週間後に目やにがぴたリと止まった。 産業上の利用の可能性  My eyes and eyes were worried. The tablet of Example 7 was taken three times a day, three tablets at a time, and stopped abruptly one week later. Industrial applicability
本発明の医薬組成物は、 上記のように、 漢方伝来の生薬と、 抗酸化剤との相乗 効果にょリ、 副作用の恐れもなく、 多くの眼疾患、 特に加齢眼疾患の難病とされ る黄斑変性症にも改善効果が見られるという、 従来に類を見ない効果を持つもの である。  As described above, the pharmaceutical composition of the present invention has many synergistic effects between herbal medicines introduced from Kampo medicine and antioxidants, has no fear of side effects, and is considered to be an intractable disease of many eye diseases, especially age-related eye diseases. It has an unprecedented effect in that macular degeneration also has an improving effect.

Claims

請 求 の 範 囲 The scope of the claims
1 清肝明目作用を有する動物胆に、 抗酸化剤としてビタミンおょぴノまたは力 口チノイドを配合したことを特徴とする眼疾患改善用及び眼の機能維持用医薬組 成物 (1) A pharmaceutical composition for improving eye diseases and maintaining eye function, comprising vitamin bile or oral tinoid as an antioxidant added to an animal bile having a clear liver action.
2 請求項 1の組成物にプルーベリー濃縮末を配合したことを特徴とする眼疾患 改善用及び眼の機能維持用医薬組成物  2. A pharmaceutical composition for improving ocular diseases and maintaining eye function, wherein the composition according to claim 1 is blended with concentrated pruberry.
3 請求項 1の上記動物胆は、 鯉胆、 マムシ胆、 およぴ羊胆であることを特徴と する眼疾患改善用及び眼の機能維持用医薬組成物  3. The pharmaceutical composition for improving ocular diseases and maintaining ocular function, wherein the animal gall of claim 1 is carp gall, viper gall, and sheep gall.
4 請求項 1の上記抗酸化剤は、 ビタミン C、 ビタミン E、 ァスタキサンチン、 リコピンを含む抗酸化剤中から、 適宜に選択、 配合されることを特徴とする眼疾 患改善用及び眼の機能維持用医薬組成物  (4) The antioxidant of claim 1, which is appropriately selected and blended from antioxidants including vitamin C, vitamin E, astaxanthin, and lycopene, for improving ocular diseases and for eye functions. Pharmaceutical composition for maintenance
5 請求項 1ないし 4の何れかの組成物に、 さらに真珠貝末を配合したことを特 徴とする眼疾患改善用及び眼の機能維持用医薬組成物  (5) A pharmaceutical composition for improving ocular diseases and maintaining ocular function, characterized in that pearl mussel powder is further added to the composition according to any one of (1) to (4).
6 請求項 1ないし 5の何れかの組成物に、 清肝明目用成分としてェビスグサ、 およぴ千里光末および/またはォォバコを配合したことを特徴とする眼疾患改善 用及び眼の機能維持用医薬組成物  (6) The composition according to any one of (1) to (5), wherein Ebisugusa, and Chisato Mitsue and / or Oobaco are blended as ingredients for Ameyomyei, for improving ocular diseases and maintaining eye function. Pharmaceutical composition for
7 請求項 1ないし 6の何れかの組成物に、 清肝熱薬として白菊花、 養肝陰薬と して枸杞を配合したことを特徴とする眼疾患改善用及ぴ眼の機能維持用医薬組成 物  7.A medicament for improving ocular diseases and maintaining ocular function, wherein the composition according to any one of claims 1 to 6 is combined with Shiragiku flower as a seizure liver fever and Mushroom as a hepatotropic agent. Composition
8 請求項 1ないし 7の何れかの組成物に、 さらに山茱萸 (サンシュュ) 、 高麗 人参、 メグスリノキ、 田七人参末、 チンピ末、 八つ目鰻濃縮末、 カイケィ地黄茎 茶末、 椎茸菌エキス末、 丹参葉末、 食用コンドロイチン末、 中の適宜の成分を配 合したことを特徴とする眼疾患改善用及び眼の機能維持用医薬組成物  8 The composition according to any one of claims 1 to 7, further comprising Sanshu, Ginseng, Megusulinoki, Rice field, Chimpi powder, Eight-thick eel enriched powder, Kaikei ground yellow stem tea powder, Shiitake fungi extract powder , A pharmaceutical composition for improving ocular diseases and maintaining ocular function, characterized by combining the appropriate components of: ginseng leaf powder, edible chondroitin powder, and
9 請求項 1ないし 8の何れかの組成物中、 カロチノイドはマイクロカプセルに 封入して配合したことを特徴とする眼疾患改善用及び眼の機能維持用医薬組成物 1 0 請求項 9の組成物中、 マイクロカプセルに封入したカロチノイドはァスタ キサンチンおょぴノまたはリコピンであることを特徴とする眼疾患改善用及ぴ眼 の機能維持用医薬組成物 1 1 請求項 1 0の組成物中、 カロチノィドは、 担体に吸着させることによリ粉 末状にして配合したことを特徴とする眼疾患改善用及び眼の機能維持用医薬組成 物 9. The pharmaceutical composition according to any one of claims 1 to 8, wherein the carotenoid is encapsulated in a microcapsule and is blended. Wherein the carotenoid encapsulated in the microcapsules is astaxanthin or lycopene, and is a pharmaceutical composition for improving ocular diseases and maintaining ocular function. 11. The pharmaceutical composition according to claim 10, wherein the carotenoid is formulated into a powder form by adsorbing the carotenoid on a carrier, and the composition is used for improving ocular diseases and maintaining eye function.
1 2 請求項 1 0の組成物中、 カロチノイドは、 担体に吸着させることによリ粉 末状にしてマイクロ力プセルに封入したことを特徴とする眼疾患改善用及ぴ眼の 機能維持用医薬組成物  12. The pharmaceutical composition according to claim 10, wherein the carotenoid is adsorbed on a carrier, converted into a powder form, and encapsulated in a microforce capsule. Composition
1 3 請求項 1ないし 1 2のいずれ'かの組成物において、 改善の対象となる眼疾 患は黄斑変性症である医薬組成物  13.The pharmaceutical composition according to any one of claims 1 to 12, wherein the eye disease to be improved is macular degeneration.
PCT/JP2001/006672 2001-08-02 2001-08-02 Medicinal compositions having effects of ameliorating eye diseases and holding eye functions WO2003013556A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2001/006672 WO2003013556A1 (en) 2001-08-02 2001-08-02 Medicinal compositions having effects of ameliorating eye diseases and holding eye functions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2001/006672 WO2003013556A1 (en) 2001-08-02 2001-08-02 Medicinal compositions having effects of ameliorating eye diseases and holding eye functions

Publications (1)

Publication Number Publication Date
WO2003013556A1 true WO2003013556A1 (en) 2003-02-20

Family

ID=11737617

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/006672 WO2003013556A1 (en) 2001-08-02 2001-08-02 Medicinal compositions having effects of ameliorating eye diseases and holding eye functions

Country Status (1)

Country Link
WO (1) WO2003013556A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007050423A2 (en) * 2005-10-26 2007-05-03 Yasuhiro Itagaki Skin rejuvinating supplement
CN102835670A (en) * 2012-09-24 2012-12-26 彭贵书 Cordyceps militaris braised pork and lamb liver slice and manufacturing method
CN109288050A (en) * 2017-12-01 2019-02-01 天津地天科技发展有限公司 A kind of three kinds of composition of raw materials and its manufacture craft of Amti-sanility health-care food and food

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57179121A (en) * 1981-04-27 1982-11-04 Showa Kagaku Kogyo Kk Remedy for oculopathy
JPS60186263A (en) * 1984-03-06 1985-09-21 Osaka Chem Lab Food for promoting health of eye
JPH0597690A (en) * 1991-04-10 1993-04-20 Nissei Marine Kogyo Kk Composition having action to maintain ophthalmic function and to remit ophthalmic disease
EP0586303A1 (en) * 1992-09-01 1994-03-09 L'oreal Cosmetic or pharmaceutical composition containing an association between a peroxydase and an anti-singlet oxygen agent
JPH08242815A (en) * 1995-03-10 1996-09-24 Sawada Nogyo Kyodo Kumiai Extraction of acer nikoense and beverage, udon (noodles), buckwheat noodles, candies, boiled rice or rice gruel using the same
JPH08259451A (en) * 1995-03-24 1996-10-08 Lion Corp Microcapsule having multicore structure including natural carotenoid and its use
EP0981969A1 (en) * 1998-08-26 2000-03-01 Basf Aktiengesellschaft Carotinoid compositions comprising a mixture of beta-carotene, lycopene and lutein
JP2001046030A (en) * 1999-08-02 2001-02-20 Tama Seikagaku Kk Production of blueberry-extracted essence

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57179121A (en) * 1981-04-27 1982-11-04 Showa Kagaku Kogyo Kk Remedy for oculopathy
JPS60186263A (en) * 1984-03-06 1985-09-21 Osaka Chem Lab Food for promoting health of eye
JPH0597690A (en) * 1991-04-10 1993-04-20 Nissei Marine Kogyo Kk Composition having action to maintain ophthalmic function and to remit ophthalmic disease
EP0586303A1 (en) * 1992-09-01 1994-03-09 L'oreal Cosmetic or pharmaceutical composition containing an association between a peroxydase and an anti-singlet oxygen agent
JPH08242815A (en) * 1995-03-10 1996-09-24 Sawada Nogyo Kyodo Kumiai Extraction of acer nikoense and beverage, udon (noodles), buckwheat noodles, candies, boiled rice or rice gruel using the same
JPH08259451A (en) * 1995-03-24 1996-10-08 Lion Corp Microcapsule having multicore structure including natural carotenoid and its use
EP0981969A1 (en) * 1998-08-26 2000-03-01 Basf Aktiengesellschaft Carotinoid compositions comprising a mixture of beta-carotene, lycopene and lutein
JP2001046030A (en) * 1999-08-02 2001-02-20 Tama Seikagaku Kk Production of blueberry-extracted essence

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KOJI KADOYA: "Oxidative stress in the cataract formation", ATARASHII GANKA, vol. 15, no. 5, 1998, pages 631 - 634, XP002947514 *
ROSE R.C.: "ocular oxidants and antioxidant protection", OCULAR OXIDANTS AND ANTIOXIDANTS, vol. 217, no. 4, 1998, pages 397 - 407, XP002947513 *
TADAHISA HIRAMITSU: "Me", GENDAI IRYOU, vol. 25, no. 10, 1993, pages 143 - 146, XP002947516 *
TADAHISA HIRAMITSU: "Ocular damage by UV lights", J. ACT. OXYG. FREE. RAD., vol. 4, no. 1, 1993, pages 28 - 34, XP002947515 *
YOSHINORI IMANISHI ET AL.: "Koitan ganyu hozai no gansei hiro ni taisuru koka", KISO TO RINSHO, vol. 18, no. 5, 1984, pages 405 - 416, XP002947512 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007050423A2 (en) * 2005-10-26 2007-05-03 Yasuhiro Itagaki Skin rejuvinating supplement
WO2007050423A3 (en) * 2005-10-26 2007-10-11 Yasuhiro Itagaki Skin rejuvinating supplement
CN102835670A (en) * 2012-09-24 2012-12-26 彭贵书 Cordyceps militaris braised pork and lamb liver slice and manufacturing method
CN109288050A (en) * 2017-12-01 2019-02-01 天津地天科技发展有限公司 A kind of three kinds of composition of raw materials and its manufacture craft of Amti-sanility health-care food and food

Similar Documents

Publication Publication Date Title
CN103417733B (en) A kind of pharmaceutical composition of alleviating asthenopia
CN105878573A (en) Composition for relieving visual fatigue
JP2010502597A (en) Eye disease treatment
JP2008271878A (en) Novel food and drink
CN102225087A (en) Xanthophyll compound preparation with powerful eye-protecting effect
WO2014023082A1 (en) Composition used for improving macular pigment density in eyes and preventing or treating age-related macular degeneration
CN105106049B (en) A kind of composition and preparation method for eye-care
CN105362501A (en) Radiation-preventing and eyesight-protecting beverage, and preparation method thereof
Yazhen et al. Anthocyanins: Novel antioxidants in diseases prevention and human health
CN110354204A (en) It is a kind of to have effects that the composition of improving eyesight and its preparation, application method
CN105232907A (en) Beverage capable of invigorating kidney and strengthening Yang and making method thereof
CN103316032B (en) Compositions containing hydroxytyrosol and application thereof
CN109430856A (en) A kind of eye-protecting improves the Ricipe for health care food and preparation method thereof of visual fatigue
JP2002017295A (en) Health auxiliary food product having activity for ameliorating eye disease and activity for keeping function of eye
JP2005065525A (en) Lutein- and blueberry-containing drink
CN101416741A (en) Health-care food for relieving visual fatigue
CN101433635A (en) Composition with function for alleviating eyestrain and preparation method thereof
CN106620639A (en) Lutein-containing compound plant eye mask with effect of supplementing eye nutrients to resist wrinkles
CN105106286A (en) Health product with effects of protecting eyes and improving eyesight
CN103446475A (en) Eye aging-resisting health product and preparation thereof
CN101433639A (en) Composition with function for alleviating eyestrain and preparation method thereof
CN106578323A (en) Eyesight-improving functional ice cream and preparation method thereof
CN106490604A (en) A kind of anti-oxidant Green Tea Extract health care product and preparation method thereof
WO2003013556A1 (en) Medicinal compositions having effects of ameliorating eye diseases and holding eye functions
CN101433638A (en) Composition with function for alleviating eyestrain and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CN JP KR

Kind code of ref document: A1

Designated state(s): AU CN JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP